Frictionless search, where users receive insights rather than wading through raw content, has become the benchmark for information platforms. Publishers must strike a balance between the degree of autonomy built into those capabilities and the user’s needs.
Komodo and Nasdaq launch NMCI, merging real-world healthcare data with financial insights. It signals a major shift as healthcare data becomes essential for investors and capital markets strategy.
eLife’s Journal Impact Factor (JIF) eligibility expires next month. Support for the journal indicates the declining importance of the JIF as a standalone metric. This brave new world of transparency amid a multiplicity of metrics opens opportunities and challenges for metrics providers.
D&B’s new move into identity resolution overlays rich business and consumer profiles and signals to create enriched B2B2C profiles. The move puts it in a rarified class of enterprise-level sales and marketing data providers that can do it at this depth and breadth.
CAS and Cleveland Clinic have partnered to accelerate drug discovery in brain health, combining IBM quantum computing capabilities with decades of innovation in scientific data. This alliance reflects CAS’s continued evolution from a trusted content provider to a leading force in healthcare AI.
Global law firm Cleary Gottlieb’s recent acquisition of AI-focused startup Springbok signifies a landmark move when legal services stopped consuming technology and started competing on it.
The customer data platform (CDP) space continues to consolidate as big agencies and enterprise software platforms buy in, niche players specialize, and the middle gets squeezed. Companies evaluating or using CDPs will need to monitor if their tool gets acquired and how things might change.
Siemens’ April 2025 acquisition of Dotmatics marks a decisive leap into the future of life sciences, blending data-driven drug discovery with industrial-scale automation. This move signals a shift toward an integrated, AI-powered ecosystem that is redefining pharmaceutical R&D and manufacturing.
2024 was disappointing to most dealmakers on the M&A front, although an improvement from 2023. While 2025 began with high optimism, economic and trade uncertainty have pushed many to say that happy days may not quite be here again.
The LBR-ALM merger combines global scale with niche expertise, creating a powerful new platform that will reshape how legal professionals access, utilize, and integrate critical information across markets.
In today’s maturing markets, productizing content, data, and services offers a strategic path to scalable growth. This article outlines how organizations can unlock new revenue streams, drive efficiency, and deliver repeatable value by treating capabilities as products.
D&B is changing hands—again. Can a legendary data provider remain relevant in a world that values embedded insights over raw information? This piece explores why reinvention is no longer optional – and what must happen next.
This new analysis dives into the $100 billion Healthcare & Pharma Tech and Information Services market. The market grew by 9% in 2024, driven by demand for data and predictive analytics, digital medicine, and the capabilities offered by generative AI.
With Notified, EQ gains access to the communications software and intelligence stack and gets closer to customers during crisis events. West divests an asset no longer core to its infrastructure business. Cison, Meltwater, and Onclusive may end up in similar spots as their growth slows.
This new analysis delves into the $25 billion Scholarly Research market. The market grew by just under 4% in 2023, driven by demand for workflow solutions to improve research efficiency, and the possibilities offered by generative AI tools.